Defining safe injection distances for trigger point pain treatment
Avoid Pneumothorax: Identification of the Interscapular Area Trigger Point Injection Safe Zone in Different Positions (Sitting/Prone)
This study is trying to find the safest distance for trigger point injections to help people with muscle pain while reducing the risk of lung problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 211 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06664359 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the safe distance between the skin and pleura during trigger point injections to minimize the risk of pneumothorax. Using ultrasonographic imaging, the study will measure this distance in both sitting and prone positions during inhalation and exhalation. By establishing these measurements, the study seeks to enhance patient safety during trigger point injections, which are commonly used to treat myofascial pain syndrome. The findings could lead to improved protocols for administering these injections.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with Myofascial Pain Syndrome who are scheduled for trigger point injections.
Not a fit: Patients under 18 years of age or those with additional diseases, active infections, or known lung diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce the risk of complications associated with trigger point injections, enhancing patient safety.
How similar studies have performed: While the approach of using ultrasound guidance in trigger point injections is established, this specific focus on safe distance measurements is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with Myofascial Pain Syndrome * patients scheduled for trigger point injections due to Myofascial Pain Syndrome. Exclusion Criteria: * under 18 years of age, * additional diseases other than Myofascial Pain Syndrome, * the presence of active infection in the interscapular area where ultrasound imaging and measurements will be performed, * lesions that disrupt skin integrity or affect subcutaneous and muscle structures such as anomalies or masses that could impair imaging quality * individuals with known lung diseases * not consent to participate in the study."
Where this trial is running
Ankara
- Ankara University Department of Anesthesiology and Reanimation — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Süheyla Karadağ Erkoç, MD
- Email: suheylakaradag@hotmail.com
- Phone: +905063994839
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.